SB0435
Public Health - Medetomidine and Xylazine Consumer Protection Act
Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or xylazine product unless the purchaser provides proof the intended use is for institutional, veterinary, or scientific purposes; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine or xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine or xylazine product to maintain certain records; etc.
Basic Information
- Status
- Chaptered
- Session
- 2026 Regular Session
- Type
- Unknown
- Cross-filed
- HB0417
Links
- State Link
- View on State Website
- LegiScan URL
- View on LegiScan
Upcoming Events
Hearing
February 11, 2026
at 14:00
📍 Finance
Hearing - Finance Committee
Sponsors
Folden